Sept 28 (Reuters) - Here's what you need to know about the
coronavirus right now:
Japan to lift emergency curbs
Japan will lift a state of emergency in all regions on
Thursday for the first time in nearly six months, as the number
of new cases and deaths falls and the strain on the medical
system eases, Prime Minister Yoshihide Suga said.
Daily cases have fallen nationwide from more than 25,000
last month to 1,128 on Monday, but the opening will be gradual
with some curbs on restaurants and large-scale events staying in
place for about a month.
The government will introduce a certification system whereby
only approved restaurants can stay open until 9 p.m and a ban on
serving alcohol will be lifted everywhere unless local governors
Russia reports record daily deaths
Russia on Tuesday reported 852 deaths from COVID-19 in the
past 24 hours, above the previous all-time high recorded last
week amid a spike in cases.
Authorities reported 21,559 new cases in the past 24 hours,
slightly down from 22,236 on Monday.
New York hospitals fire, suspend staff who refuse vaccine
New York hospitals on Monday began firing or suspending
healthcare workers for defying a state order to get the COVID-19
vaccine, and resulting staff shortages prompted some hospitals
to postpone elective surgeries or curtail services.
New York City Mayor Bill de Blasio told a news conference
the city's hospitals were not yet seeing a major impact from the
mandate, adding he worried about other areas of the state where
vaccination rates are lower.
A spokeswoman for Catholic Health, one of the largest
healthcare providers in Western New York, said it had reached
full compliance, counting staff members who had been vaccinated,
those with exemptions and some who had been suspended without
Sydney's unvaccinated warned of social isolation
Sydney residents who are not vaccinated against COVID-19
risk being barred from various social activities even when they
are freed from stay-at-home orders in December, New South Wales
state Premier Gladys Berejiklian warned on Tuesday.
Under a roadmap to exit lockdown in Australia's biggest
city, unvaccinated people are already subject to delays in
freedoms that will be gradually granted to inoculated residents
between Oct. 11 and Dec. 1.
Sanofi ditches mRNA vaccine
Sanofi is dropping plans for its own mRNA-based COVID-19
vaccine because of the dominance achieved by BioNTech-Pfizer and
Moderna in using the technology to fight the pandemic, the
company said on Tuesday.
The move highlights the challenges of competing in
particular with pioneer BioNTech, which rose from obscurity
through its alliance with pharma major Pfizer last year. They
have delivered close to 1.5 billion doses so far to become the
Western world's largest COVID-19 vaccine maker.
French healthcare group Sanofi will instead focus on efforts
with British partner GlaxoSmithKline to bring another COVID-19
vaccine candidate to market based on the more conventional
protein-based approach, where mass trials are ongoing.
Pfizer submits data for vaccine in younger children
Pfizer and BioNTech on Tuesday submitted initial trial data
for their COVID-19 vaccine in children aged 5 to 11 and said
they would make a formal request with U.S. regulators for
emergency use in the coming weeks.
India's drug regulator on Tuesday allowed vaccine maker
Serum Institute to enroll kids aged 7-11 years for its trial of
U.S. drugmaker Novavax's vaccine.
(Open https://tmsnrt.rs/2FkV6wq in a web browser to see
Reuters global coronavirus tracker)
(Compiled by Linda Noakes; Editing by Alex Richardson)